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ABSTRACT: Peptide inhibitors of Methuselah (Mth), a G protein-coupled receptor (GPCR), were reported
that can extend the life span of Drosophila melanogaster. Mth is a class B GPCR, which is characterized
by a large, N-terminal ectodomain that is often involved with ligand recognition. The crystal structure of
the Mth ectodomain, which binds to the peptide inhibitors with high affinity, was previously determined.
Here we report the predicted structures for RWR motif peptides in complex with the Mth ectodomain.
We studied representatives of both Pro-class and Arg-class RWR motif peptides and identified ectodomain
residues Asp139, Phe130, Asp127, and Asp78 as critical in ligand binding. To validate these structures,
we predicted the effects of various ligand mutations on the structure and binding to Mth. The binding of
five mutant peptides to Mth was characterized experimentally by surface plasmon resonance, revealing
measured affinities that are consistent with predictions. The electron density map calculated from our
MD structure compares well with the experimental map of a previously determined peptide/Mth crystal
structure and could be useful in refining the current low-resolution data. The elucidation of the ligand
binding site may be useful in analyzing likely binding sites in other class B GPCRs.
G protein-coupled receptors (GPCRs)1 constitute a super-
family of transmembrane proteins that play critical roles in
transmitting extracellular signals to the interior of the cell.
Methuselah (Mth) is a class B (secretin-like) GPCR that was
previously shown to be involved in stress response and
biological aging (1). Like other class B GPCRs, Mth has a
large (195 residues) amino-terminal extracellular domain
essential for ligand binding (2). However, the sequence
similarity of the mth gene to other class B GPCRs is observed
solely within the transmembrane regions (1). The crystal
structure shows that the Mth ectodomain consists primarily
of -sheets (3), revealing a topology distinct from that of
other hormone receptors such as the corticotropin-releasing
factor (CRF) or glucose-dependent insulinotropic polypeptide
(GIP) receptors (4, 5).
Recently, Ja et al. reported a series of peptide antagonists
that inhibit Mth signaling and extend Drosophila melano-
gaster life span (6). Since the extracellular N-terminal
domains of other hormone GPCRs have been shown to be
properly folded and function in ligand binding (7-9), Ja et
al. used mRNA display selection to identify high-affinity
peptide ligands targeting the Mth ectodomain (6). The
selected peptides contain a highly conserved consensus,
[R/P]xxWxxR, which is denoted as the RWR motif. The
crystal structure of a selected peptide and the ectodomain
complex was reported, but the coordinates of the ligand could
not be resolved. Therefore, it was not possible to extract the
detailed atomistic description of the ligand-receptor interac-
tions that would be critical in understanding the properties
of the binding site.
Here we use computational tools to predict atomistic
models of the Mth ectodomain complex structure for four
high-affinity peptide ligands. We also compute the electron
density map with our atomistic structure of the complex for
comparison with the experimental map (6). We then use our
predicted structure to carry out a computational mutagenesis
study that suggests alternative peptide ligands that might
improve or diminish the binding affinity. Experimental
measurements of binding affinity for five mutant peptides
are subsequently performed and found to be consistent with
our predictions. Our predicted structures suggest additional
experimental validation studies that could be helpful in
characterizing the binding of other Mth ligands.
METHODS
Modeling of the Mth Ectodomain. Two X-ray crystal
structures of the Mth ectodomain (the N-terminal 188
residues of Mth without the signal sequence) were published
with and without a peptide inhibitor in complex (PDB ID:
2PZX and 1FJR, respectively) (3, 6). The resolution for the
cocrystal structure was not sufficient to determine the
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coordinates for the ligand. Since the RMSD of CR atoms
between these two X-ray structures is 0.65 Å, we chose the
structure with the better resolution (PDB ID: 1FJR). We then
refined this crystal structure computationally by equilibrating
it in explicit water solvent for 1 ns. Only chain A was
extracted from the dimer in the unit cell. Two Pb2+ ions close
to Asp or Glu residues were replaced with Zn2+ ions, and
the water molecules within 5 Å from the protein were
retained. The hydrogen atoms were placed using the Whatif
program (10). The system was fully solvated into an
equilibrated water box of 64 × 74 × 70 Å3 using the visual
molecular dynamics (VMD) molecular graphics program
(11). The VMD autoionize plugin was then used to randomly
place the ions necessary to neutralize the system. The
resulting system contained 27643 atoms within the periodic
unit cell: 2993 protein atoms, 24642 water atoms, and 2 Zn2+
and 6 Na+ atoms.
The system was minimized using 5000 conjugate gradient
steps and equilibrated subsequently at 310 K for 100 ps while
the protein coordinates were kept fixed. Next, the full system
was minimized using 5000 conjugate gradient steps with no
restraints and then equilibrated at 100 K for 1 ns. This
equilibrated system was finally subjected to 5000 steps of
conjugate gradient minimization. This system was gradually
heated from 0 K to the target temperature using Langevin
molecular dynamics with a damping coefficient of 1 ps-1.
A constant pressure of 1 atm was maintained using the
Langevin piston method.
All simulations used periodic boundary conditions, and
the electrostatic interactions were computed using the particle
mesh Ewald (PME) method. The simulations were carried
out with the NAMD 2.6 (12) parallel molecular dynamics
code using the CHARMM22 force field (FF) (13, 14) for
proteins and the TIP3P water model (15).
Building the Peptide Ligands. Two peptides representing
the Pro and Arg classes of RWR motif peptides (LP1 and
LR1 in Table 1) were built as canonical R-helices using the
Biograf program. Based on the spacing of the critical residues
in the RWR motif, the ligand regions contacting the binding
site are likely to be helical. The side chains of the peptide
were replaced using the SCREAM side chain optimization
program (V. W. T. Kam and W. A. Goddard III, to be
published). These side chain conformations were further
optimized with three cycles of annealing molecular dynamics
using the SGB implicit solvent protocol (16). The isolated
helix was heated from 50 to 600 K and cooled down to 50
K in 50 K temperature steps while the coordinates of the
backbone atoms were fixed. At each temperature the
equilibration was carried out for 300 fs. The annealing MD
was performed using the DREIDING FF (17) with the
charges from CHARMM22. MPSim was used for all energy
and force calculations (18). The cell multipole method was
used for the calculation of nonbonded interactions (19).
The optimized helix structure was then equilibrated in
explicit water solvent as described previously. The equilibra-
tion was performed at 100 K for 1 ns, then 200 K for 1 ns,
and 310 K for 1 ns. The equilibrated structure was minimized
with a conjugate gradient of 5000 steps and used for the
docking study.
Docking of the LP1 Ligand to the Mth Ectodomain. To
search for the LP1 peptide binding site on the Mth
ectodomain, rigid docking was carried out using ZDOCK
(20). The search area on Mth was limited to residues
126-144, 148-159, and 164-188, based on the approximate
binding regions provided by the electron density map from
the experimental crystal structure of the LP1-Mth ectodomain
complex (6). From the 2000 configurations generated, we
selected the 80 configurations in which the N · · ·O distance
of the salt bridge between R8 and Asp139 was within 4 Å.2
Here we assumed a close interaction between R8 in LP1
(which is one of the critical residues identified in the previous
study) and Asp139. Asp139 is a negatively charged residue
present in the putative binding crevice. The side chain
conformations of the peptide ligands were replaced using
SCREAM, and then the ligands were minimized with 50
conjugate gradient steps. These calculations, including the
following optimization steps, were carried out using the
DREIDING FF and CHARMM22 charges with the MPSim
MD code (18).
Among the top 20 configurations ranked by the interaction
energy (sum of intermolecular Coulombic, van der Waals,
and hydrogen bond energies), we chose two configurations
in which W5, another residue critical for receptor binding,
had favorable interactions with Mth. These two ligand-protein
complexes were further optimized as follows: the ligand was
subjected to conjugate gradient minimization to an RMS
force of 0.5 kcal mol-1 Å-1 followed by 10 ps NVT
dynamics at 50 K using SGB implicit solvent; then we
minimized it to an RMS force of 0.3 kcal mol-1 Å-1. We
next used SCREAM to replace side chain conformations of
the peptide ligand and of Mth residues within 3 Å from the
ligand. Finally, the entire complex structure was minimized
to 0.3 kcal mol-1 Å-1 of RMS force with conjugate gradient.
The structures for both complexes were subsequently equili-
brated in an explicit water box as described previously. The
water box was chosen to extend by ∼8 Å from all atoms of
the complex. This equilibration was carried out for 3 ns (100
K for 1 ns, then 200 K for 1 ns, and 310 K for 1 ns).
Docking of the LR1 Ligand to the Mth Ectodomain. The
LR1 peptide was docked to the receptor by matching the
CR atoms of residues 5-8 (which include the key W5 and
R8 residues of the RWR motif) to those of the LP1 ligand
in the equilibrated structure of the complex. From the last
500 ps of the 1 ns MD trajectory for the LR1 ligand we
selected 4 snapshots out of 50 (the snapshots were taken
every 10 ps) that had no clashes with the receptor after being
matched and minimized them further. Side chains of the
ligand and of receptor residues within 3.5 Å of the ligand
2 Throughout the text, the Mth ectodomain residues are denoted by
their three-letter abbreviations while peptide ligand residues are denoted
by their one-letter codes.
Table 1: Peptide Ligands for the Mth Ectodomaina
a Consensus residues from the RWR motif ([R/P]xxWxxR) are in
bold (6). b LP1 and LP2 correspond to a 15-mer and a 22-mer of R8-01
in ref 6, respectively. LR1 and LR2 correspond to R8-12 and R8-14.
c From ref 6.
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were replaced using SCREAM, and the complex structure
was minimized to an RMS force of 0.5 kcal mol-1 Å-1. The
final best complex structure was chosen based on the FF
energy and subsequently equilibrated in the explicit water
solvent by following the same procedures as for the LP1
ligand complex. Here we extended the equilibration time to
3 ns at 310 K to allow for full conformational relaxation of
the docked ligand since the LR1 ligand has an internal proline
residue that induced a kink in the helix of the equilibrated
free ligand. To decrease the equilibration time scale and assist
conformational change, the side chain conformations in the
cavity around R2 of the ligand (which was expected to be
critical in interacting with the receptor (6)) were reassigned
using SCREAM. After replacement, the complex was further
equilibrated for 1 ns. This newly assigned complex structure
showed better interaction energy (-407.77 ( 25.88 kcal/
mol) than the original complex structure (-389.61 ( 38.18
kcal/mol). Here the interaction energy includes electrostatic
and van der Waals interactions and is averaged over the last
1 ns trajectory.
Computational Mutagenesis Study. Starting from the 1 ns
equilibrated Mth/LP1 complex structure, five residues (W5,
R8, Y9, L11, and R15) of the LP1 ligand were selected for
computational mutagenesis. For each of these five residues
we considered the 19 natural amino acids excluding proline.
We selected 10 side chain conformations using SCREAM
with the 0.1 Å rotamer library; then we conjugate gradient
minimized for 10 steps with MPSim and selected the rotamer
with the best energy. To reduce the bias in interaction
energies due to electrostatic interactions with charged groups,
each charged residue was neutralized by protonating or
deprotonating before calculating the differential interaction
energy. The structure of the ligand-protein complex was
minimized to 0.25 kcal mol-1 Å-1 of the RMS force after
the neutralization step. The energies from these calculations
are listed in Table 2.
Based on these calculations we selected five mutations of
the LP1 ligand (W5K, W5F, Y9F, L11Q, and R15Q) as good
tests of our predicted ligand-protein structure (the reasons
why they were chosen are explained in the Results and
Discussion section). Each of these was equilibrated in explicit
water solvent to allow for conformational relaxation due to
perturbation from mutation. To minimize the effect of the
initial solvent and ion configurations on conformational
change, we started with the fully solvated wild-type (WT)
complex structure and mutated the corresponding residue
with the same mutant rotamer previously optimized. Any
water molecules that clashed were removed. The system was
reneutralized by adding or deleting Cl- counterions as
necessary. Each system was first subjected to a minimization
of 1000 steps, and then the solvent molecules were equili-
brated for 100 ps at 310 K while the coordinates of Mth/
ligand complex structure were fixed. Finally, the entire
system was equilibrated for 2 ns at 310 K. The MD
simulation was carried out with the NAMD 2.6 program as
described previously.
Experimental Binding Analysis of Peptides Using Surface
Plasmon Resonance (SPR). LP1 (FPSSWLQRYYLAKRR)
and mutant peptides (W5K, W5F, Y9F, L11Q, and R15Q)
were synthesized and purified (>95%) by Genscript Corp.
(Piscataway, NJ) with N-terminal acetylation and C-terminal
amidation. Lyophilized peptides were dissolved in ddH2O
and quantitated by measuring absorbance at 280 nm. C-
terminal biotinylated Mth ectodomain was prepared as
described previously (6). SPR measurements were performed
at 25 °C on a Biacore T100 instrument (Biacore, Piscataway,
NJ). A CM5-streptavidin chip was prepared in-house by
standard NHS/EDC amine coupling (Biacore) and achieved
∼6000 RU of immobilized streptavidin per flow cell.
Biotinylated Mth ectodomain was immobilized to different
flow cells of the CM5-streptavidin chip to surface densities
of approximately 500, 600, and 800 RU. HBS-EP+ (Biacore;
10 mM HEPES at pH 7.4, 150 mM NaCl, 3 mM EDTA,
and 0.05% (v/v) surfactant P20) was used as the running
buffer, and flow cell 1 was left as a streptavidin negative
control for all experiments. To collect kinetic data, a
concentration series for each peptide was injected for 90 s
at a flow rate of 100 µL/min. Numerous buffer blank
injections were also included for double referencing with
the streptavidin negative control surface. Peptides were
allowed to dissociate for >5 min, which allowed the signal
to return to baseline before injection of the next sample. Raw
data were processed with Biacore T100 evaluation software
Table 2: Predicted Changes in Binding Energy (kcal/mol) from
Combinatorial Mutation Calculations of the LP1 Mth Peptide Inhibitora
a Delphi solvation energy is included. Relative to the binding energy
in WT, BE (WT) ) -81.79 kcal/mol; negative means more favorable
binding. The shading indicates cases selected for experimental
validations.
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using a 1:1 bimolecular interaction model, and KD values
were calculated (kd/ka) from the determined on and off rates.
Rate constants were determined from each Mth-containing
flow cell and are reported as averages ((SD) except for the
W5F mutant, which yielded measurable data from only the
flow cell with the highest density of immobilized Mth
ectodomain.
RESULTS AND DISCUSSION
In Silico Equilibration of Apo Receptor and Free Peptide
Ligands. After the Mth ectodomain was equilibrated in the
explicit water box for 1 ns, we found that the overall folding
topology remained the same as the initial X-ray crystal
structure (RMSD of CR atoms ) 0.47 Å). This indicates
that the force field parameters describe our current system
well. The LP1 ligand remained in the initial R-helical
conformation during the 1 ns equilibration, and for the LR1
ligand we observed the proline kink in the middle of the
helix, as expected. The bend angle was 27.5° for the final
equilibrated structure after 1 ns and 17.5° for the conforma-
tion showing the best FF energy after docking (snapshot at
940 ps).
Characterization of the Predicted Binding Site of the LP1
Peptide Ligand. After equilibration of two candidate
ligand-protein complexes at 310 K for 1 ns, the interactions
between the LP1 ligand and the receptor were identified. We
then selected the putative ligand-protein structure (1 ns
snapshot of Figure 1) based on the nature of the important
nonbonding intermolecular interactions and the interaction
energy (-347.68 ( 27.23 vs -213.31 ( 24.44 kcal/mol,
averaged over 1 ns). This final complex structure was further
equilibrated for 5 ns. Three representative snapshots at 1, 3,
and 5 ns are shown in Figure 1, along with the initial
minimized structure. Figure 2 presents the changes in
distances over the 5 ns equilibration for several key residue
pairs involved in the intermolecular interactions.
Two defining residues of the RWR motif, W5 and R8,
were previously determined to be critical in binding to Mth
(6). The initial predicted structure has W5 making favorable
hydrophobic interactions with the aromatic residues Phe130
(5.0 Å at 1 ns, the centroid-to-centroid distance) and Phe153
(6.1 Å). However, the contact with Phe153 loosens after 1.5
ns (∼8.0 Å). The indole nitrogen of W5 also forms a
hydrogen bond with Asp139, which is quite stable during
the 5 ns (remaining at ∼3 Å).
The other key residue, R8, interacts via salt bridge with
Asp139 (∼2.6 Å), which remains buried and constant during
the dynamics (Figure 2b). R8 also forms a salt bridge with
Glu136 at early times (2.77 Å at 1 ns), but this becomes
weaker later (4.46 Å at 5 ns). R8 also forms a hydrogen
bond (∼2.7 Å) with the backbone carbonyl oxygen of
Tyr131.
At the C-terminus of the ligand, R15 makes a salt bridge
with Asp127 (2.67 Å at 1 ns). Since R15 is exposed to
solvent, we find fluctuations in the distance between R15
and Asp127, from 2.7 and 15 Å, as water molecules move
in and out. Interestingly, R15 switches its interaction to
Asp78 after 2 ns and then back to Asp127 after 4 ns (Figure
2a). R15 is located at the terminus of the ligand, which allows
for this conformational flexibility. These two Asp residues
present in different loop regions enable R15 to maintain
receptor interactions while remaining free to sweep through
space. Hence, this binding interaction is likely to have some
favorable aspects of both enthalpy and entropy. Arginine
residues C-terminal to the RWR motif are weakly conserved
in the previously identified peptide ligands (6), with the
location of the Arg residues varying by several residues
between sequences. The presence of these Asp residues in
the loop regions of Mth could explain this variation.
We identified two other favorable contacts: F1 initially
interacts closely with Phe153, and later the backbone nitrogen
forms a salt bridge with Glu137 (at 3 ns) and then Glu136
(at 5 ns). We find that P2, which is one of the consensus
residues of the RWR motif, does not interact directly with
the receptor. However, the flexibility in the conformation
induced by Pro likely plays a role in permitting F1 to make
contacts with the receptor. In addition, S4 contacts Glu136
through hydrogen bonding, but with fluctuations.
Characterization of the Predicted Binding Site of the LR1
Peptide Ligand. Binding of the LR1 ligand to the Mth
ectodomain reduces the kink induced by the proline residue
FIGURE 1: Binding of the LP1 ligand to the Mth ectodomain after 0, 1, 3, and 5 ns equilibration. The residues from the receptor (green) are
in three-letter code and those from the ligand (magenta) are in single-letter code. Hydrogen bonds and aromatic interactions are specified
with black dotted lines and red arrows, respectively. The HBPLUS program was used to calculate hydrogen bonds (maximum D-A distance
) 3.9 Å, minimum D-H-A angle ) 90.0°).
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(from a bend angle of 17.5° to <10°). The intermolecular
contacts between the LR1 ligand and the ectodomain are
shown in Figure 3 after equilibration for 5 ns. W5 and R8
show the same interactions with the ectodomain as for the
LP1 ligand, except that Glu136 no longer interacts with the
peptide. S4 of LP1, which interacts with Mth Glu136, is
replaced with V4 in the LR1 ligand. This leaves Glu136 in
the LR1/Mth complex exposed and solvated with water
molecules. Therefore, we would expect that mutation of
Glu136 might reduce the binding affinity for the LP1 ligand
preferentially and assaying this mutation could provide
validation for our models.
R2, a critical residue of the conserved RWR motif, shows
favorable electrostatic interaction with Asp154. This contact
is fairly stable throughout the equilibration as shown in
Figure 4c. R2 also contacts the side chain of Gln138 through
a hydrogen bond, which is formed after 1 ns and preserved
thereafter.
R15 forms a salt bridge with Asp78 as observed in the
LP1 case. However, in the LR1 case this interaction remains
tight throughout the equilibration since the C-terminus of
the LR1 ligand is extended from R15 by additional residues.
R17 is in the proximity of Asp127 but appears to interact
weakly. During the first 1 ns equilibration, the N · · ·O
distance between them fluctuates between 2.5 and 10.5 Å.
After ∼1.7 ns R17 gets closer to Asp127, but a water
molecule still intervenes between them occasionally.
F12 has a strong aromatic interaction with Tyr131, and
its backbone carbonyl group forms a hydrogen bond with
Asn79 at earlier times. The carbonyl group of M1 also
contacts Gln138.
FIGURE 2: Changes during 5 ns MD simulation of key intermolecular interactions in the Mth/LP1 complex. Shown are distances (in Å)
between side chain heavy atoms. (a) N · · ·O between R15 and Asp127 (gray solid) and between R15 and Asp78 (black dotted), (b) two
N · · ·O pairs between R8 and Asp139, (c) centroid to centroid between W5 and Phe130 (gray solid) and W5 and Phe153 (black dotted), and
(d) O · · ·O between S4 and Glu136 (gray solid) and N · · ·O between W5 and Asp139 (black dotted).
FIGURE 3: Binding of the LR1 ligand to the Mth ectodomain after 0, 1, 3, and 5 ns equilibration. The receptor is colored green and the
ligand magenta. Hydrogen bonds and the aromatic interactions are specified with dotted lines and arrows, respectively.
12744 Biochemistry, Vol. 47, No. 48, 2008 Heo et al.
The interaction energy between the ligand and the
ectodomain was averaged over the last 4 ns to compare the
energetics between the LP1 and LR1 ligand cases. The LR1
ligand showed better interaction energy than the LP1 ligand
(-437.34 ( 44.58 vs -310.97 ( 78.33 kcal/mol), in
qualitative agreement with experimental binding affinities
(6). The relatively large standard deviation for the LP1 case
reflects greater conformational fluctuations, indicating that
the binding of the LP1 ligand would be entropically more
favorable as previously described.
Characterization of the Predicted Binding Sites of the LP2
and LR2 Ligands. The LP2 ligand has seven additional amino
acids extended from the N-terminus of LP1 (Table 1).
Starting with the 1 ns equilibrated Mth/LP1 complex
structure in Figure 1, we added these seven residues in the
R-helical conformation. The torsion angles for the unraveled
amino-terminal F-P in the LP1 ligand were modified to be
R-helical. However, this full R-helix conformation caused a
clash with the receptor, and therefore these additional seven
residues likely form a random coil. In any case, they would
not have much contact with the receptor since they are hung
peripherally. This may explain the similar binding affinities
between the LP1 and LP2 peptides, measured previously (6).
The structure of the Mth/LR2 complex was built from the
Mth/LR1 structure by using SCREAM to mutate the corre-
sponding residues. Since the LR2 ligand does not have the
proline that caused the kink in LR1 (it was replaced with
phenylalanine), the torsion angle was modified to assume a
straight R-helix conformation after replacement of the amino
acids. The two additional amino-terminal residues in LR2
were built in the extended conformation first and then
optimized with annealing molecular dynamics. The final
equilibrated complex structure is shown in Figure S1 in
Supporting Information. During the entire trajectory of the
1 ns equilibration, three arginine residues common with
the LR1 ligand formed salt bridges with Asp residues of the
receptor. The aromatic interactions of W7 from the LR2
ligand (corresponding to W5 of the LR1 peptide) also remain
stable.
Comparison of Predicted and Experimental Electron
Density Maps. We computed the electron density map from
our Mth/LP1 complex structure using the CCP4 program
suite (21) for comparison with the experimental density map
published in the previous study (6). The unit cell for the
Mth/LP1 complex structure was built with the same space
group as the crystal structure (PDB ID: 2PZX). Starting with
the structure factor file deposited in the Protein Data Bank,
we recalculated the structure factors and phases for our
complex structure and computed the electron density map.
The density map covering the peptide ligand for the 5 ns
equilibrated structure is shown in Figure 5a. The density
maps also overlapped well with the experimental density map
of the ligand (Figure 5b), supporting our prediction of the
LP1 peptide binding mode. These computational results could
be useful in refining the relatively low-resolution crystal
structure.
Computational Mutagenesis Study. We carried out a
computational mutagenesis study for the LP1 ligand to design
better alternative peptide ligands and also to provide
candidates for mutagenesis experiments. Five residues were
considered for mutation: L11, Y9, W5, R8, and R15.
We selected L11 because it is located on the boundary of
the ligand-receptor contact and is therefore exposed to
solvent even though it is nonpolar. Moreover, the nearby
Asn79 has no interaction partner. When replacing this L11
with 18 other amino acids (see Table 2 for the energies), we
found three mutations with dramatically enhanced binding
energy, K (by 8.2 kcal/mol), R (by 11.4 kcal/mol), and Q
(by 5.6 kcal/mol), with all of them forming a hydrogen bond
with Asn79. We selected L11Q for experimental measure-
ments since the other cases would introduce charges and
hence might affect the ligand structure.
FIGURE 4: Changes during 5 ns MD simulation of key intermolecular interactions in the Mth/LR1 complex. Shown are distances (in Å)
between side chain heavy atoms. (a) N · · ·O between R15 and Asp78 (gray solid) and between R17 and Asp127 (black dotted), (b) N · · ·O
between R8 and Asp139 (gray solid) and between W5 and Asp139 (black dotted), (c) N · · ·O between R2 and Asp154 (gray solid) and
between R2 and Gln138 (black dotted), and (d) centroid to centroid between F12 and Tyr131 (gray solid) and W5 and Phe130 (black
dotted).
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We chose Y9 as a control mutation candidate since we
expected that mutations of Y9 would have little effect on
binding. Although it is close to Phe130 and W5, Y9 does
not interact tightly with the receptor. Most predicted muta-
tions made the interaction worse (Table 2), and the changes
were small as expected. However, mutation to R enhanced
the affinity due to hydrogen bonding with the backbone
carbonyl group. A conserved mutation to either F or W barely
affected binding; thus we decided to assay Y9F experimentally.
Since W5, R8, and R15 all strongly interact with the
receptor, mutation of these residues generally leads to a
dramatic decrease in the calculated binding energy. One
exception is the W5K mutation, which the calculations
suggested would improve binding (by ∼5 kcal/mol) by
forming a salt bridge with Asp139 (which previously made
a hydrogen bond with the side chain nitrogen of W5). In
contrast, mutation of either R8 or R15 to K was predicted
to not improve binding even though these mutations preserve
the positive charge. For the R8K mutation, the K residue
can no longer reach Glu136 leading to loss of this contact.
For R15K, Asp127 formed a salt bridge, but the binding
energy was 11 kcal/mol smaller than the WT. These results
are compatible with the previous observation that Arg and
not Lys is prevalent in this region of the peptide ligands (6).
To avoid inducing large conformational instability in the
peptide ligand itself, we chose to experimentally assay W5F
and R15Q, in addition to W5K.
Experimental Binding Study of Mutant Ligands. Based on
our computational mutagenesis predictions, we measured the
binding kinetics of five mutant ligands (L11Q, Y9F, W5F,
W5K, and R15Q) by SPR. The biotinylated Mth ectodomain
was immobilized on the surface of a sensor chip while the
peptides were in solution. Binding of the ligands to the Mth
ectodomain was observed as a refractive index change on
the sensor chip surface and was measured in real time in
resonance units (RU).
The results with the LP1 wild-type (WT) peptide compare
well with previous measurements and may reflect slight
differences in the synthetic peptides tested (peptides in this
study had N- and C-terminal acetylation and amidation,
respectively) (6). The L11Q, Y9F, and R15Q mutants
exhibited similar rate constants to the WT peptide. Mutations
to the strongly conserved W5 residue drastically reduced
binding, with W5F exhibiting a KD of 12 µM and W5K
showing no binding to the Mth ectodomain at the highest
concentrations tested (1 µM).
Molecular Dynamics Simulations for Mutant Complex
Structures. In the computational mutagenesis study described
above, we did not allow conformational changes from the
single-residue mutations. For optimal comparison to the
experimental results, we carried out MD simulations in
explicit water solvent for the complex structures of the five
experimentally tested peptide mutants, allowing for full
conformational relaxation. Indeed, we see that some initial
contacts change within the 2 ns equilibration. The interactions
in the core regions composed of W5, R8, Asp139, and
Phe130 remain fairly strong for all five cases, as in the WT.
We can observe some changes in contacts between the
receptor and the ligand, which vary case by case. The final
equilibrated structures are shown in Figure 6. The binding
energies for these mutant complex structures were computed
in the same way as shown in Table 2 of the computational
mutagenesis study. We also calculated the nonbond interac-
tion energy between the ligand and the receptor residues
within 5 Å from the ligand (Table 3).
(i) L11Q. We made this experimental mutation because
the combinatorial mutation calculations suggested that it
might increase binding by ∼6 kcal/mol. However, the full
solvent MD found that the initial hydrogen bond between
Q11 and Asn79 is unstable, breaking after 0.5 ns of
equilibration. At 2 ns, the side chain of Q11 forms a
hydrogen bond with the hydroxyl group of Tyr131. However,
FIGURE 5: Calculated electron density maps (EDM). (a) The calculated EDM from the predicted Mth/LP1 complex structure after 5 ns
equilibration. The Mth ectodomain is in green, LP1 peptide in magenta, and EDM in blue. For clarity, only the part of the map covering
the ligand is shown. (b) Comparison with the experimental map (6). The CR trace of the crystal structure is in cyan and the experimental
map in orange. The calculated maps from equilibrated structures of 1, 3, and 5 ns are colored magenta, yellow, and blue, respectively.
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this contact is water-mediated with an average distance of
∼6 Å after equilibration. Indeed, the L11Q mutation caused
the salt bridge of R15 with Asp127 to break, becoming water-
mediated. However, L11Q leads to improved hydrogen
bonding of Glu136 with R8 and S4. The net result from the
MD is that L11Q improves the binding (by ∼13-23 kcal/
mol, as expected from the combinatorial mutation calcula-
tions). The experiments find a slightly decreased binding
affinity (18-24 nM), indicating very similar binding.
(ii) W5F. We expected W5F to decrease binding (by ∼9
kcal/mol). Obviously, the hydrogen bond with Asp139 shown
for the indole nitrogen of W5 is no longer available for W5F.
Indeed, the MD shows much decreased binding (by ∼6-11
kcal/mol). The salt-bridge interaction between R15 and
Asp127 on the C-terminus of the ligand is preserved in the
MD. However, this mutation leads to a loss of the hydrogen
bonding of F1 to the Glu residue, indicating a loosening of
the N-terminus of the ligand. The experiments find a dramatic
decrease in binding (18 nM to 12 µM) as expected from the
prediction.
(iii) W5K. We expected from the combinatorial mutation
calculations that W5K might improve the binding (by ∼5
kcal/mol). This mutation of the aromatic residue to a
nonaromatic results in the loss of hydrophobic contacts with
Phe130 and Phe153. However, the initial hydrophilic interac-
tions remain during the 2 ns equilibration, including the
contact of K5 with Asp139. The net result from the MD is
much worse binding (by 6-8 kcal/mol). The experiments
observed no binding at the highest peptide concentrations
tested (KD >15 µM). To explore the origin of the lack of
measureable binding, we carried out MD calculations for
isolated W5K in water solvent (Figure 7), starting with the
R-helical docked conformation, and found that the W5K
peptide unraveled in ∼2 ns. Hence, the W5K peptide likely
suffers a higher entropic cost than that of the WT peptide
upon binding to Mth. In silico, this would lead to a low
probability of observing the predicted W5K complex where
the helical conformation of the ligand was retained.
(iV) R15Q. We expected from the combinatorial mutation
calculations that this mutant would have dramatically
decreased binding (by ∼13 kcal/mol). Indeed, the MD
simulation finds that the initial hydrogen bond of Q15 with
Asp127 breaks, making a salt bridge to R14. However, the
R15Q preserves the hydrophobic interaction between W5 and
Phe153 in the MD, whereas this interaction is not preserved
FIGURE 6: Five mutant complex structures after 2 ns equilibrations in the fully solvated water box (∼23000 atoms, 54 × 86 × 48 Å3).
Table 3: Comparison of Experimental KD Values (nM) of the LP1
Peptide and Mutant Ligands with Energies (kcal/mol) Calculated both
from the Combinatorial Mutation Calculations and from the MD
Simulationsa
KD (exptl) ∆BE (calcComb)b ∆BE (calcMD)c ∆Eint (calc)d
WT 18.5 0.00 0.00 0.00
L11Q 24.5 -5.63 -13.49 -22.66
Y9F 49.5 -0.18 -11.00 -12.88
W5F 12000 8.81 5.66 10.78
W5K no binding -4.62 6.30 8.02
R15Q 37.7 12.92 -8.63 0.91
a Relative to WT, for the 2 ns equilibrated complex structures after
mutation. b Calculated binding energy from combinatorial mutation
calculation (from Table 2). c Calculated binding energy after MD;
Delphi solvation energy is included; BE (WT) ) -68.25 kcal/mol.
d Intermolecular interaction energies, calculated for the residues within 5
Å of the ligand; Eint (WT) ) -61.62 kcal/mol.
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in the MD for the WT. Moreover, the hydrogen bond of
Glu136 to S4 is lost during the MD of the R15Q mutant.
The net result from the MD is that the binding for R15Q is
essentially the same (∼1 kcal/mol worse) as for the WT.
The experiments find a slightly decreased binding affinity
(from 18 to 38 nM), indicating very similar binding.
(V) Y9F. Compared with Y9 in the WT, the mutated F
shows more conformational fluctuation. The hydroxyl group
of Y9 in WT holds it closer to the receptor through a water-
mediated hydrogen bond with the backbone of the receptor.
The centroid-to-centroid distance between F9 and Phe130
represents this behavior (initially ∼5 Å and occasionally ∼8
Å (Figure S2-(b) in Supporting Information)). W5 has the
original hydrophobic contact with Phe153, which becomes
loose after further equilibration in WT. The experiments find
a slightly decreased binding affinity (from 18 to 49 nM)
indicating very similar binding.
To summarize, the experiments and predictions indicated
that L11Q, Y9F, and R15Q mutant ligands exhibit compa-
rable interactions to the WT LP1 peptide. We expected that
W5F would lead to worse binding, which was confirmed by
the MD simulation and experimental results. For the W5K
complex, we thought that an additional hydrophilic interac-
tion from mutation of W5 to K might compensate for the
missing aromatic interactions. However, MD simulations of
the W5K peptide alone and in complex with Mth suggested
a more severe decrease in binding, which was experimentally
verified as W5K showed no measureable affinity to Mth.
The changes in binding energy are not in quantitative
agreement with experiments. Several possibilities for this
include the following: (1) the energies in the dynamics
fluctuate greatly as various charged side groups and coun-
terions move about, (2) no account is taken of the entropic
effects upon binding, and (3) the length of the dynamics
might not sample all significant binding modes. Regardless,
the predictions on how the binding changes from the
combinatorial mutation calculations and the MD simulations
are qualitatively consistent with experiments, indicating
which ones should lead to comparable binding. Thus such
calculations are likely to distinguish bad binders from good
binders.
CONCLUSION
The docking study of the Mth ectodomain with the peptide
ligands was carried out using rigid docking methods followed
by side chain replacement and force field based scoring. The
RWR motif of the ligands showed favorable aromatic and
electrostatic interactions with the ectodomain, demonstrating
the importance of these residues on binding as suggested
from the conservation seen in the previous experimental
study (6). Indeed, these studies show that the critical residues
of the protein are Asp139 interacting with W5 and R8,
Phe130 with W5, either Asp78 or Asp127 with R15, and
Asp154 with R2 in the LR ligands. This provides a number
of predictions that can be subjected to experimental tests.
Using the predicted structures, we illustrate the combina-
torial mutation calculation strategy to predict interesting
mutations for experimental study. This is a complement to
experimental screening or selection studies. Based on the
computational mutagenesis results, we measured the kinetics
of binding of the mutant peptide ligands with the Mth
ectodomain. Here we found that conformational relaxation
of the mutant complex structures from MD simulations is
essential to obtain qualitative correlations with the experi-
ments. The computational predictions are consistent with
experiments, but clearly an improvement in binding scoring
will be needed to use such methods for optimizing ligands.
It is encouraging that the current method of docking such
a large peptide ligand to a receptor protein leads to results
in apparently excellent agreement with experiments. We
expect that the binding characteristics examined in this study
for the Mth ectodomain will provide insight helpful in
investigating interactions between the N-terminal domains
of other class B GPCRs and their peptide ligands. To
understand the overall process of GPCR function, it will be
necessary to model ligand binding to the entire receptor
structure, including the transmembrane domains. Our studies
of the ectodomain-ligand binding are the first step for
elucidating this process.
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Kinetics analysis of peptide binding by surface plasmon
resonance (Table S1), binding charateristics of the LR2
ligand into the Mth ectodomain (Figure S1), changes in
distance during the 2 ns MD simulation of key intermolecular
interactions in mutant complexes (Figure S2), and SPR
sensorgrams of LP1 wild-type (WT) and mutant peptides
with the Mth ectodomain (Figure S3). This material is
available free of charge via the Internet at http://pubs.acs.org.
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